Portfolio comparison
Medtronic Minimed vs Immatics Biotechnologies
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Medtronic Minimed
Patents indexed
2
Year range
2014 – 2018
Most recent
2018
biotechmedical_devicessoftwareconsumer_electronics
Top Patents2 enriched
US 8882665· 2014
How Continuous Glucose Monitors Estimate Blood Sugar Levels Accurately
US 9854998· 2018
How Devices Precisely Track Glucose Across Body Compartments
Activity by Decade
2010s2
Company B
Immatics Biotechnologies
Patents indexed
7
Year range
2019 – 2024
Most recent
2024
biotechpharmaceuticalimmunotherapyoncologygene_editing
Top Patents7 enriched
US 11407807· 2022
Using Specific Immune Cells to Fight Cancers Like Lung and Breast Cancer
US 10377797· 2019
Training Immune Cells to Fight Cancer Using Specific Markers
US 10314897· 2019
How a Specific Protein Fragment Can Train Immune Cells to Fight Cancer
Activity by Decade
2010s3
2020s4
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.